The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on αvB3 integrin expression in cancer cell lines

Oncology Reports

Volumn 20, Issue 4, 2008, Pages 941-952

  Wietrzyk, Joanna ^a   Filip, Beata ^a   Milczarek, Magdalena ^a   Klopotowska, Dagmara ^a   Maciejewska, Magdalena ^a   Dabrowska, Krystyna ^a   Kurzepa, Aneta ^a   Dzimira, Stanislaw ^b   Madej, Janusz ^b   Kutner, Andrzej ^c  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^c INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

Calcitriol; Cancer cell lines; Integrin vB3; PRI 2191

Indexed keywords

CALCITRIOL; PRI 2191; TACALCITOL; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCITRIOL; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DIHYDROXYCHOLECALCIFEROLS; HUMANS; INTEGRIN ALPHAVBETA3; NEOPLASM INVASIVENESS;

EID: 54949092797     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000094     Document Type: Article

References (48)

1. 3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis 12: 195-202, 1994.
2. 3 In: Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism. Norman AW, Schaefer K, Coburn JW, De Luca HF, Fraser D, Grigoleit HG, van Herrath D (eds). Walter de Gruyter, Berlin, pp587-589, 1977.
3. 3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11: 221-229, 2000.
4. 3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 31: 21-28, 2003.
5. 3 on tumor cell invasion to the extracellular matrix in human fibrosarcoma HT1080 cells and its correlation with laminin. Tumour Biol 18: 69-79, 1997.
6. 3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma. J Lab Clin Med 133: 120-128, 1999.
7. 3. J Bone Miner Res 6: 1021-1027, 1991.
8. 3. Proc Natl Acad Sci USA 87: 9751-9755, 1990.
9. Sepulveda VA, Weigel NL and Falzon M: Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE. Steroids 71: 10-115, 2006.
10. Narayanan R, Sepulveda VA, Falzon M and Weigel NL: The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific. J Biol Chem 279: 47298-47310, 2004.
11. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood 78: 75-82, 1991.
12. 3. J Steroid Biochem Mol Biol 67: 71-78, 1998.
13. 3 and retinoic acid. Exp Cell Res 249: 279-290, 1999.
14. 3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells. Cell Cycle l: 410-415, 2002.
15. Asou H, Koike M, Elstner E, Cambell M, Le J, Uskokovic MR, Kamada N and Koeffler HP: 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines. Blood 92: 2441-2449, 1998.
16. 3 and phorbol myristate acetate is dependent on osteopontin synthesis and the αvβ3 integrin. Connect Tissue Res 35: 163-171, 1996.
17. 3 up-regulates expression of the osteoclast integrin αvβ3. J Biol Chem 268: 1456-1461, 1993.
18. 3. J Biol Chem 268: 27371-27380, 1993.
19. 3. Steroids 72: 930-938, 2007.
20. 3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol 164: 133-143, 2000.
21. Carreiras F, Denoux Y, Staedel C, Lehmann M, Sichel F and Gauduchon P: Expression and localization of αv integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma. Gynecol Oncol 62: 260-267, 1996.
22. Gruber G, Hess J, Stiefel C, Aebersold DM, Zimmer Y, Greiner RH, Studer U, Altermatt HJ, Hlushchuk R and Djonov V: Correlation between the tumoral expression of β3-integrin and outcome in cervical cancer patients who had undergone radiotherapy. Br J Cancer 92: 41-46, 2005.
23. Hieken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L and Das Gupta TK: β3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 63: 169-173, 1996.
24. Switala-Jelen K, Dabrowska K, Opolski A, Lipinska L, Nowaczyk M and Gorski A: The biological functions of β3 integrins. Folia Biol (Praha) 50: 143-152, 2004.
25. Mizejewski GJ: Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222: 124-138, 1999.
26. Felding-Habermann B, Mueller BM, Romerdahl CA and Cheresh DA: Involvement of integrin αV gene expression in human melanoma tumorigenicity. J Clin Invest 89: 2018-2022, 1992.
27. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A and Mueller BM: Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858, 2001.
28. Felding-Habermann B, Fransvea E, O'Toole TE, Manzuk L, Faha B and Hensler M: Involvement of tumor cell integrin αβ3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis 19: 427-436, 2002.
29. Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF and Ellis LM: αvβ3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res 63: 2079-2087, 2003.
30. Ben-Ze'ev A: Cytoskeletal and adhesion proteins as tumor suppressors. Curr Opin Cell Biol 9: 99-108, 1997.
31. Dayam R, Aiello F, Deng J, Wu Y, Garofalo A, Chen X and Neamati N: Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents. J Med Chem 49: 4526-4534, 2006.
32. 2. (24E)-(1S)-24-Dehydro-24a-homo-1, 25-dihydroxyergocalciferol and congeners. Steroids 67: 789-798, 2002.
33. Opolski A, Wietrzyk J, Chrobak A, Marcinkowska E, Wojdat E, Kutner A and Radzikowski C: Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines. Anticancer Res 19: 5217-5222, 1999.
34. Opolski A, Wietrzyk J, Siwinska A, Marcinkowska E, Chrobak A, Radzikowski C and Kutner A: Biological activity in vitro of side-chain modified analogues of calcitriol. Curr Pharm Des 6: 755-765, 2000.
35. 3 (PRI-2191). Steroids 69: 629-635, 2004.
36. 3. Anticancer Drugs 18: 447-457, 2007.
37. Boratynski J: Colorimetric micromethod for the determination of protein in solutions with silver ions and dithizone. Anal Biochem 148: 213-219, 1985.
38. 3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother 41: 37-45, 1995.
39. 3 and ceramide reduce the invasion of tumor cells through extracellular matrix components by elevating protein phosphatase-2A. Invasion Metastasis 16: 280-290, 1996.
40. 3 reduces tumor motility and metastasis. Invasion Metastasis 13: 169-177, 1993.
41. Wang X, Ferreira AM, Shao Q, Laird DW and Sandig M: β3 integrins facilitate matrix interactions during transendothelial migration of PC3 prostate tumor cells. Prostate 63: 65-80, 2005.
42. Damjanovich L, Fulop B, Adany R and Nemes Z: Integrin expression on normal and neoplastic human breast epithelium. Acta Chir Hung 36: 69-71, 1997.
43. Sato T, Konishi K, Kimura H, Maeda K, Yabushita K, Tsuji M and Miwa A: Vascular integrin β3 and its relation to pulmonary metastasis of colorectal carcinoma. Anticancer Res 21: 643-647, 2001.
44. Sato T and Miwa A: Ets-1 and integrin β3 for lung metastasis from colorectal cancer. APMIS 110: 347-353, 2002.
45. Pelczynska M, Switalska M, Maciejewska M, Jaroszewicz I, Kutner A and Opolski A: Antiproliferative activity of vitamin D compounds in combination with cytostatics. Anticancer Res 26: 2701-2705, 2006.
46. Prufer K, Racz A, Lin GC and Barsony J: Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J Biol Chem 275: 41114-41123, 2000.
47. 3-stimulated transcription. J Biol Chem 271: 20650-20654, 1996.
48. Koszewski NJ and Rowan A: Heterodimer requirement for gene regulation by Vitamin D in variant OK cells. Steroids 68: 307-314, 2003.